A multinational outbreak of nosocomial fusarium meningitis occurred among immunocompetent patients who had undergone surgery with epidural anesthesia in Mexico. The pathogen involved had a high predilection for the brain stem and vertebrobasilar arterial system and was associated with high mortality from vessel injury. Effective treatment options remain limited; in vitro susceptibility testing of the organism suggested that it is resistant to all currently approved antifungal medications in the United States. To highlight the severe complications associated with fusarium infection acquired in this manner, we report data, clinical courses, and outcomes from 13 patients in the outbreak who presented with symptoms after a median delay of 39 days.
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
By Nora Strong, M.D., Grant Meeks, M.D., Sunil A. Sheth, M.D., Louise McCullough, M.D., Ph.D., Julian A. Villalba, M.D., Chunfeng Tan, M.D., Ph.D., Andrew Barreto, M.D., Audrey Wanger, Ph.D., Michelle McDonald, D.O., Peter Kan, M.D., M.P.H., Hashem Shaltoni, M.D., Jose Campo Maldonado, M.D., Victoria Parada, M.D., Ameer E. Hassan, D.O., Sarah Reagan-Steiner, M.D., M.P.H., Tom Chiller, M.D., M.P.H.T.M., Jeremy A.W. Gold, M.D., Dallas J. Smith, Pharm.D., M.A.S., and Luis Ostrosky-Zeichner, M.D. et al.
Due to global market conditions, you may experience a delivery delay for your print issue of the New England Journal of Medicine. Your subscription also includes full access to the NEJM.org website. We regret any print delays and are working to ensure all issues are delivered as soon as possible. Thank you for your patience. This article is available to subscribers. Subscribe now. Already have an account? Sign in
